These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8616909)

  • 1. Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias.
    Waud WR; Gilbert KS; Grindey GB; Worzalla JF
    Cancer Chemother Pharmacol; 1996; 38(2):178-80. PubMed ID: 8616909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.
    Waud WR; Gilbert KS; Harrison SD; Griswold DP
    Cancer Chemother Pharmacol; 1992; 31(3):255-7. PubMed ID: 1361163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of in vivo cross-resistance with 4'-thio-ara-C against drug-resistant murine P388 and L1210 leukemias.
    Waud WR; Gilbert KS; Secrist JA
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):399-403. PubMed ID: 21069340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
    Hertel LW; Boder GB; Kroin JS; Rinzel SM; Poore GA; Todd GC; Grindey GB
    Cancer Res; 1990 Jul; 50(14):4417-22. PubMed ID: 2364394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E; Szmigielska A; Robak T
    Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a murine P388 leukemia line resistant to thiarabine.
    Waud WR; Parker WB; Gilbert KS; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(1):14-27. PubMed ID: 22257207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a murine P388 leukemia line resistant to clofarabine.
    Waud WR; Gilbert KS; Parker WB; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):826-38. PubMed ID: 22060549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Cyclic Hydroxamic Acid CHA-5 against Drug-Resistant P388 Leukemia Strains.
    Goncharova SA; Vystorop IV; Raevskaya TA; Konovalova NP
    Bull Exp Biol Med; 2017 Jul; 163(3):385-388. PubMed ID: 28744633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
    Marańda E; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(2):113-9. PubMed ID: 9613709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia.
    Waud WR; Harrison SD; Gilbert KS; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1991; 27(6):456-63. PubMed ID: 1849465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
    Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
    Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.
    Waud WR; Harrison SD; Temple CG; Griswold DP
    Cancer Chemother Pharmacol; 1992; 29(3):190-4. PubMed ID: 1733551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
    Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
    J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
    Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.
    Namba T; Kodama R; Moritomo S; Hoshino T; Mizushima T
    Cell Death Dis; 2015 Jun; 6(6):e1795. PubMed ID: 26111057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.
    Jordheim LP; Cros E; Gouy MH; Galmarini CM; Peyrottes S; Mackey J; Perigaud C; Dumontet C
    Clin Cancer Res; 2004 Aug; 10(16):5614-21. PubMed ID: 15328204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
    Chen P; Chien PY; Khan AR; Sheikh S; Ali SM; Ahmad MU; Ahmad I
    Anticancer Drugs; 2006 Jan; 17(1):53-61. PubMed ID: 16317290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M; Ido M; Nagao Y; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M
    Leuk Res; 1991; 15(8):675-81. PubMed ID: 1895749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
    Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
    Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.